Currently Viewing
Blood Cancer Awareness Month: What You Need to Know
September 27, 2019 – Jessica Skarzynski
FDA Approves Frontline Darzalex Regimen to Treat Patients With Multiple Myeloma
September 26, 2019 – Katie Kosko
CURE New Issue Alert: 2019 Hematology Special Issue
September 25, 2019 – Katie Kosko and Jessica Skarzynski
CURE's Clinical Trial Corner: September 2019
September 25, 2019 – Kristie L. Kahl
Survey Shows Lung Cancer Stigma Has Decreased, More Awareness Still Needed
September 24, 2019 – Kristie L. Kahl
Expert Offers Advice for Women With Ovarian Cancer
September 24, 2019 – Kristie L. Kahl
What Women Should Know About the FDA's Endometrial Cancer Combination Approval
September 23, 2019 – Kristie L. Kahl
Join the Next #CureConnect Tweet Chat on Living With Cancer
September 23, 2019 – Jessica Skarzynski
Preventing Lymphedema: What Patients Need to Know
September 23, 2019 – Pat Whitworth, MD

Blood Cancer Awareness Month: What You Need to Know

For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.
BY Jessica Skarzynski
PUBLISHED September 27, 2019
For Blood Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space:



 
  1. Stem cell transplantation has been used to treat patients with different types of blood cancers, such as leukemia, lymphoma and multiple myeloma. Learn more about the basics of stem cell transplantation here.
  2. Certain oncology treatments can raise the risk of developing yet another cancer. In this feature from our latest Hematology Special Issue, we take a closer look at what it’s like living with a secondary blood cancer.
  3. Given their recent presence in the news, a lymphoma expert discusses implant removal, reconstruction and the signs of breast implant-associated anaplastic large cell lymphoma.
  4. After learning to walk again following a life-changing multiple myeloma diagnosis, Richard Bell tells us about how he took on Mount Washington as a part of CURE’s Moving Mountains for Multiple Myeloma program.
  5. Following its announcement of covering CAR-T cell therapy nationwide, the Centers for Medicare and Medicaid Services has now made this highly-priced, but life-saving, treatment available to many who would not otherwise have access to it at their cancer centers.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the Lymphoma Cancer CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In